- World’s first CRISPR-based medicine wins approval in U.K. STAT
- UK becomes 1st country to approve gene therapy treatment for sickle cell, thalassemia AOL
- This gene-editing therapy could cure sickle cell disease, and it’s close to FDA approval The Hill
- UK authorises gene therapy for blood disorders in world first Reuters
- Vertex and CRISPR Therapeutics Announce Authorization of the First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), by the United Kingdom MHRA for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta T Business Wire
- View Full Coverage on Google News
Tag Archives: STAT
Concerns raised on One Medical’s concierge medicine plan – STAT
- Concerns raised on One Medical’s concierge medicine plan STAT
- ‘This is literally the plot to Cyberpunk’: Customers are concerned about Amazon now offering healthcare to Prime subscribers The Daily Dot
- Amazon Launches Virtual Healthcare Service for $9 a Month Kiplinger’s Personal Finance
- Amazon reenters health care market with Prime virtual appointment service that costs $9 per month Fortune
- Jeff Bezos’ Amazon Prime Rolls Out Brand New Healthcare Benefit Offering 24/7 On-Demand Virtual Care For $9 A Month And RxPass: ‘We’re Making It Easier For Prime Members To Take Care Of Their Health’ Yahoo Finance
- View Full Coverage on Google News
HPV cancer vaccine study demonstrates efficacy – STAT
- HPV cancer vaccine study demonstrates efficacy STAT
- Vaccinating both girls and boys against HPV is more effective, new study shows Yahoo Life
- With cancer-causing HPVs depleted by vaccination, research suggests it’s time to reevaluate screening strategies Medical Xpress
- An HPV vaccine from India: broadening possibilities for cervical cancer control The Lancet
- India’s cervical cancer vaccine found to be safe and effective as Merck’s Gardasil vaccine: Why are the findings of the new Lancet study important? The Indian Express
- View Full Coverage on Google News
FDA approves Eli Lilly ulcerative colitis treatment Omvoh – STAT – STAT
- FDA approves Eli Lilly ulcerative colitis treatment Omvoh – STAT STAT
- Lilly’s bowel disease drug gets US FDA nod for treatment in adults Reuters
- FDA Approves Lilly’s Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis | Eli Lilly and Company Investors | Eli Lilly and Company
- FDA Approves Lilly’s Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis PR Newswire
- FDA Approves Lilly’s Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis Yahoo Finance
- View Full Coverage on Google News
Biogen’s Alzheimer’s drug slows cognitive decline in early study – STAT
- Biogen’s Alzheimer’s drug slows cognitive decline in early study STAT
- More convenient form of breakthrough Alzheimer’s drug Leqembi shows promising results in study CNBC
- New studies find benefits in very early drug treatment of Alzheimer’s Financial Times
- New Data from Biogen’s Investigational Antisense Oligonucleotide (ASO) Targeting Tau Shows Promise for Potential New Generation of Treatments in Early Alzheimer’s Disease | Biogen Biogen
- Alzheimer’s drug Leqembi could be given as shots rather than IV infusion, study suggests CNN
- View Full Coverage on Google News
J&J expands global access to TB drug as popular novelist joins advocacy campaign – STAT
- J&J expands global access to TB drug as popular novelist joins advocacy campaign STAT
- Johnson & Johnson Letting Nonprofit Distribute Life-Saving Generic Tuberculosis Drug—Greatly Expanding Access In Poorer Countries Forbes
- After Pushback, J&J Allows Generics of Its TB Drug Medpage Today
- Agreement On TB Drug Is ‘Stop Gap’ That Excludes High-Burden Countries In Eastern Europe And Central Asia Health Policy Watch
- J&J allows generic production for TB drug following public dissent Pharmaceutical Technology
- View Full Coverage on Google News
Fatty liver disease was alleviated by Lilly’s ‘triple-G’ obesity drug – STAT
- Fatty liver disease was alleviated by Lilly’s ‘triple-G’ obesity drug STAT
- A new weight-loss drug dubbed the ‘triple G’ could be stronger than Ozempic, Wegovy, and Mounjaro — and as powerful as bariatric surgery Yahoo Life
- Eli Lilly (LLY) Weight-Loss Shot Gives Company’s Strongest Results in Trial Bloomberg
- Triple Agonist Retatrutide Hits New Weight-Loss Highs Medscape
- Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial The Lancet
- View Full Coverage on Google News
Should employer health plans cover GLP-1s like Ozempic? – STAT – STAT
- Should employer health plans cover GLP-1s like Ozempic? – STAT STAT
- New Obesity Drugs Come With a Side Effect of Shaming Yahoo! Voices
- Drugs that melt away pounds still present more questions than answers, but Ozempic, Wegovy, and Mounjaro could be key tools in reducing the obesity epidemic The Philadelphia Inquirer
- Unveiling the game-changing diabetic drugs: Revolutionizing weight loss and diabetes management Kevin MD
- Analysis | What You Need to Know About Drugs Like Ozempic Being Used for Weight Loss The Washington Post
- View Full Coverage on Google News
FDA approves first treatment for skin condition that causes persistent wounds, a redosable gene therapy – STAT
- FDA approves first treatment for skin condition that causes persistent wounds, a redosable gene therapy STAT
- Krystal’s Vyjuvek becomes first topical gene therapy with FDA nod to treat rare skin disease FiercePharma
- Rare Skin Blistering Condition Gets First Drug Approved Medpage Today
- Landmark victory for individuals living with DEB and their families, the FDA announced their approval of Krystal Biotech’s VYJUVEK™ for the treatment of Dystrophic Epidermolysis Bullosa (DEB). Business Wire
- FDA Approves First-Ever Topical Gene Therapy Medscape
- View Full Coverage on Google News
Hospitals pledge to protect patient privacy. Almost all their websites leak visitor data like a sieve – STAT
- Hospitals pledge to protect patient privacy. Almost all their websites leak visitor data like a sieve STAT
- 99% of hospital homepages sending user data to third parties, study finds FierceHealthcare
- Widespread Third-Party Tracking On Hospital Websites Poses Privacy Risks For Patients And Legal Liability For Hospitals healthaffairs.org
- Most hospital websites routinely transfer patient data via tracking tools SC Media
- Some Hospital Websites May Be Violating Privacy Rules By Sharing Data With Third-Party Trackers Forbes
- View Full Coverage on Google News